Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.25.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2023 $ 856,422 $ 225,250 $ 5,835 $ 973 $ (1,026,087) $ 62,393
Balance at beginning of period (in shares) at Dec. 31, 2023 384,833,546          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation   17       17
Issuance and vesting of restricted share units $ 90         90
Issuance and vesting of restricted share units (in shares) 2,613,463          
Comprehensive loss for the period       (7) (9,651) (9,658)
Balance at end of the period at Mar. 31, 2024 $ 856,512 225,267 5,835 966 (1,035,738) 52,842
Balance at end of period (in shares) at Mar. 31, 2024 387,447,009          
Balance at beginning of period at Dec. 31, 2024 $ 856,243 226,242 5,106 964 (1,125,757) $ (37,202)
Balance at beginning of period (in shares) at Dec. 31, 2024 391,231,496         391,231,496
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation   63       $ 63
Issuance and vesting of restricted share units $ 2         2
Issuance and vesting of restricted share units (in shares) 29,575          
Comprehensive loss for the period         (13,240) (13,240)
Balance at end of the period at Mar. 31, 2025 $ 856,245 $ 226,305 $ 5,106 $ 964 $ (1,138,997) $ (50,377)
Balance at end of period (in shares) at Mar. 31, 2025 391,261,071         391,261,071